Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Leukemia Nonlymphocytic Acute

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Leukemia Nonlymphocytic Acute:

Pubmed Logo
Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
1-Beta-D-arabinofuranosylcytosine (Ara-C, Cytarabine) is one of the drugs...
15th October, 2009
School of Chemical Biology and Pharmaceutical Sciences, Capital Medical Eur J Med Chem. 2009 Sep;44(9):3596-600. Epub 2009 Mar 6.
DOI Direct Link
Autism in children and adolescents with cancer.
BACKGROUND: The causes of autistic disorders (AD) are not known....
24th September, 2009
Division of Pediatric Hematology-Oncology, University of North Carolina at Pediatr Blood Cancer. 2010 Jan;54(1):144-7.
DOI Direct Link
Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
The progressive shortening of telomeres and the activation of telomerase...
21st July, 2009
Department of Hematology, First University Hospital DaLian Medical Int J Lab Hematol. 2009 Jul 15.
DOI Direct Link
[Association of HLA-A, B and DRB1 alleles with leukemia in Han population in Hunan Province]
OBJECTIVE: To investigate the association of HLA-A, B, and DRB1 alleles...
3rd April, 2009
Department of Immunology, Xiangya School of Medicine, Central South Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):1016-8.
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
Survival of patients with plasma cell disorders has increased. However,...
1st January, 2009
Department of Hematology, Mayo Clinic, 200 First Street SW, Rochester MN, Haematologica. 2008 Sep;93(9):1402-6. Epub 2008 Jul 18.
DOI Direct Link

View more research publications.

Press Releases About Leukemia Nonlymphocytic Acute:

BioPortfolio Logo
Reportlinker Adds U.S. Market for PACS and EMR 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. U.S. Market for PACS and EMR http://www.reportlinker.com/p0164740/US
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 19th November, 2009 AEGERA THERAPEUTICS INC.
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage
Reportlinker Adds Anticoagulants - A Global Market Review 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Anticoagulants - A Global Market Review http://www.reportlinker.com
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
AMT Provides Business Update for the Third Quarter 2009 18th November, 2009
AMSTERDAM, November 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in

BioNews Results for Leukemia Nonlymphocytic Acute:

RSS Logo
BioPortfolio Logo
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leu
Montana's News Station:  Nov 20 2009 11:36AM Matching: leukemia acute
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
Individual.com:  Nov 20 2009 8:41AM Matching: leukemia acute
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
Individual.com:  Nov 20 2009 8:41AM Matching: leukemia acute
TopAbstracts in Acute Lymphoblastic Leukemia (ALL) 11/18/2009
Doctors Guide:  Nov 19 2009 7:25PM Matching: leukemia acute
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
CNW Telbec:  Nov 19 2009 5:23PM Matching: leukemia acute
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

BioPortfolio Ltd. offers e-mail and postal lists for Leukemia Nonlymphocytic Acute scientists - we have details of around 154 individuals working on Leukemia Nonlymphocytic Acute .


This page has been viewed 289 times
Recent Search Terms used to find this page: taleghni hospital | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Leukemia Nonlymphocytic Acute across BioPortfolio, or for Leukemia Nonlymphocytic Acute Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.